Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Bladder Cancer

  Free Subscription


14.04.2020

1 Am J Clin Pathol
1 Anal Chem
1 Arch Ital Urol Androl
1 Biochem Genet
1 Biology (Basel)
1 Cancer Commun (Lond)
1 Cancer Imaging
1 Cancer Med
2 Cancers (Basel)
1 Clin Genitourin Cancer
1 Curr Urol Rep
1 Drug Des Devel Ther
2 Eur Rev Med Pharmacol Sci
1 EXCLI J
1 Exp Biol Med (Maywood)
1 Int J Clin Exp Pathol
1 J Biomater Sci Polym Ed
3 J BUON
1 J Cancer Educ
1 J Clin Med
6 J Urol
1 Med Sci Monit
1 Mol Genet Genomic Med
1 Molecules
1 Onco Targets Ther
1 Sci Rep
1 Urol Oncol
1 Urologe A
2 World J Urol
1 Zhonghua Bing Li Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. HWANG MJ, Kamat AM, Dinney CP, Czerniak B, et al
    Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens.
    Am J Clin Pathol. 2020 Apr 7. pii: 5816797. doi: 10.1093.
    PubMed         Abstract available


    Anal Chem

  2. BHASIN A, Sanders EC, Ziegler JM, Briggs JS, et al
    A Virus BioResistor (VBR) for the Detection of the Bladder Cancer Marker DJ-1 in Urine at 10 pM in One Minute.
    Anal Chem. 2020 Apr 6. doi: 10.1021/acs.analchem.0c00534.
    PubMed         Abstract available


    Arch Ital Urol Androl

  3. CAPECE M, Spirito L, La Rocca R, Napolitano L, et al
    Hexaminolevulinate blue light cystoscopy (Hal) assisted transurethral resection of the bladder tumour vs white light transurethral resection of the bladder tumour in non-muscle invasive bladder cancer (NMIBC) : a retrospective analysis.
    Arch Ital Urol Androl. 2020;92:17-20.
    PubMed         Abstract available


    Biochem Genet

  4. SALEH AA, Gohar SF, Hemida AS, Elgharbawy M, et al
    Evaluation of ASPM and TEF Gene Expressions as Potential Biomarkers for Bladder Cancer.
    Biochem Genet. 2020 Apr 9. pii: 10.1007/s10528-020-09962.
    PubMed         Abstract available


    Biology (Basel)

  5. PISAPIA L, Terreri S, Barba P, Mastroianni M, et al
    Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis.
    Biology (Basel). 2020;9.
    PubMed         Abstract available


    Cancer Commun (Lond)

  6. DIAO X, Cai J, Zheng J, Kong J, et al
    Association of chromosome 7 aneuploidy measured by fluorescence in situ hybridization assay with muscular invasion in bladder cancer.
    Cancer Commun (Lond). 2020 Apr 12. doi: 10.1002/cac2.12017.
    PubMed         Abstract available


    Cancer Imaging

  7. WANG Z, Shang Y, Luan T, Duan Y, et al
    Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer.
    Cancer Imaging. 2020;20:26.
    PubMed         Abstract available


    Cancer Med

  8. SHEN C, Wu Z, Wang Y, Gao S, et al
    Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
    Cancer Med. 2020 Apr 6. doi: 10.1002/cam4.3006.
    PubMed         Abstract available


    Cancers (Basel)

  9. VAGO R, Ravelli A, Bettiga A, Casati S, et al
    Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

  10. HENTSCHEL AE, Nieuwenhuijzen JA, Bosschieter J, Splunter APV, et al
    Comparative Analysis of Urine Fractions for Optimal Bladder Cancer Detection Using DNA Methylation Markers.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available


    Clin Genitourin Cancer

  11. IYER G, Tully CM, Zabor EC, Bochner BH, et al
    Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience.
    Clin Genitourin Cancer. 2020 Mar 6. pii: S1558-7673(20)30048.
    PubMed         Abstract available


    Curr Urol Rep

  12. POHAR KS
    Blue Light Cystoscopy: Indications and Outcomes.
    Curr Urol Rep. 2020;21:19.
    PubMed         Abstract available


    Drug Des Devel Ther

  13. TSAI TF, Chen PC, Lin YC, Chou KY, et al
    Miconazole Contributes to NRF2 Activation by Noncanonical P62-KEAP1 Pathway in Bladder Cancer Cells.
    Drug Des Devel Ther. 2020;14:1209-1218.
    PubMed         Abstract available


    Eur Rev Med Pharmacol Sci

  14. ZHONG XL, Wang L, Yan X, Yang XK, et al
    MiR-20a acted as a ceRNA of lncRNA PTENPL and promoted bladder cancer cell proliferation and migration by regulating PDCD4.
    Eur Rev Med Pharmacol Sci. 2020;24:2955-2964.
    PubMed         Abstract available

  15. CUI YP, Xie M, Pan WX, Zhang ZY, et al
    HOXA10 promotes the development of bladder cancer through regulating FOSL1.
    Eur Rev Med Pharmacol Sci. 2020;24:2945-2954.
    PubMed         Abstract available


    EXCLI J

  16. AGHAALIKHANI N, Zamani M, Allameh A, Mashayekhi A, et al
    Involvement of haptoglobin phenotypes and genotypes in non-muscle invasive bladder cancer: A possible prognostic marker for risk stratification.
    EXCLI J. 2020;19:351-359.
    PubMed         Abstract available


    Exp Biol Med (Maywood)

  17. KURMAN Y, Kiliccioglu I, Dikmen AU, Esendagli G, et al
    Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model.
    Exp Biol Med (Maywood). 2020 Apr 6:1535370220917367.
    PubMed        


    Int J Clin Exp Pathol

  18. GUO J, Zhang J, Yang T, Zhang W, et al
    MiR-22 suppresses the growth and metastasis of bladder cancer cells by targeting E2F3.
    Int J Clin Exp Pathol. 2020;13:587-596.
    PubMed         Abstract available


    J Biomater Sci Polym Ed

  19. WANG Y, Liu Q, Men T, Liang Y, et al
    A microfluidic system based on the monoclonal antibody BCMab1 specifically captures circulating tumor cells from bladder cancer patients.
    J Biomater Sci Polym Ed. 2020 Apr 10:1-12. doi: 10.1080/09205063.2020.1748332.
    PubMed         Abstract available


    J BUON

  20. XU A, Yang GG, Zhang Y, Zhao ST, et al
    Heptaphylline suppresses the proliferation and migration of human bladder cancer cells via induction of intrinsic apoptosis, autophagy and inhibition of beta-catenin signalling pathway.
    J BUON. 2020;25:274-279.
    PubMed         Abstract available

  21. YE Z, Liang Z, Mi Q, Guo Y, et al
    Limonene terpenoid obstructs human bladder cancer cell (T24 cell line) growth by inducing cellular apoptosis, caspase activation, G2/M phase cell cycle arrest and stops cancer metastasis.
    J BUON. 2020;25:280-285.
    PubMed         Abstract available

  22. CELIK S, Sari H, Ugur Mungan M, Yorukoglu K, et al
    Assessment of ex-vivo efficacy (oncogram) of immunotherapeutic and chemotherapeutic agents in bladder cancer: A pilot study of personalized treatment.
    J BUON. 2020;25:295-301.
    PubMed         Abstract available


    J Cancer Educ

  23. PAGUIO JA, Yao JS, Reyes MSGL, Lee G, et al
    Bladder Cancer and Google Trends: Associations Between US Search Patterns and Disease Outcomes May Show Need for Improved Awareness Strategies.
    J Cancer Educ. 2020 Apr 5. pii: 10.1007/s13187-020-01739.
    PubMed         Abstract available


    J Clin Med

  24. SIKIC D, Eckstein M, Wirtz RM, Jarczyk J, et al
    FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy.
    J Clin Med. 2020;9.
    PubMed         Abstract available


    J Urol

  25. CHANG SS
    Re: Bladder Preservation with Twice-a-Day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
    J Urol. 2020 Apr 9:101097JU0000000000001055. doi: 10.1097/JU.0000000000001055.
    PubMed        

  26. WITJES JA
    Editorial Comment.
    J Urol. 2020;203:908-909.
    PubMed        

  27. CHANG SS
    Re: PD-L1 Expression in Tumor Cells and the Immunologic Milieu of Bladder Carcinomas: A Pathologic Review of 165 Cases.
    J Urol. 2020;203:880.
    PubMed        

  28. ATALA A
    Re: Hypermethylation of FOXA1 and Allelic Loss of PTEN Drive Squamous Differentiation and Promote Heterogeneity in Bladder Cancer.
    J Urol. 2020 Apr 9:101097JU0000000000001058. doi: 10.1097/JU.0000000000001058.
    PubMed        

  29. BECERRA MF, Venkatramani V, Reis IM, Soodana-Prakash N, et al
    Health-Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial - A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical Cystectomy.
    J Urol. 2020 Apr 9:101097JU0000000000001029. doi: 10.1097/JU.0000000000001029.
    PubMed         Abstract available

  30. CHANG SS
    Re: Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery after Surgery Protocol.
    J Urol. 2020;203:660.
    PubMed        


    Med Sci Monit

  31. LIN YZ, Wu YP, Ke ZB, Cai H, et al
    Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
    Med Sci Monit. 2020;26:e920504.
    PubMed         Abstract available


    Mol Genet Genomic Med

  32. MOJARRAD M, Moghbeli M
    Genetic and molecular biology of bladder cancer among Iranian patients.
    Mol Genet Genomic Med. 2020 Apr 6:e1233. doi: 10.1002/mgg3.1233.
    PubMed         Abstract available


    Molecules

  33. GOMES ATPC, Fernandes R, Ribeiro CF, Tome JPC, et al
    Synthesis, Characterization and Photodynamic Activity against Bladder Cancer Cells of Novel Triazole-Porphyrin Derivatives.
    Molecules. 2020;25.
    PubMed         Abstract available


    Onco Targets Ther

  34. WANG X, He H, Rui W, Xie X, et al
    Long Non-Coding RNA BCAR4 Binds to miR-644a and Targets TLX1 to Promote the Progression of Bladder Cancer.
    Onco Targets Ther. 2020;13:2483-2490.
    PubMed         Abstract available


    Sci Rep

  35. HILTBRUNNER S, Mints M, Eldh M, Rosenblatt R, et al
    Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging.
    Sci Rep. 2020;10:5960.
    PubMed         Abstract available


    Urol Oncol

  36. FUJITA N, Hatakeyama S, Momota M, Kido K, et al
    Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guerin in patients with high-risk non-muscle-invasive bladder cancer.
    Urol Oncol. 2020 Apr 9. pii: S1078-1439(20)30093.
    PubMed         Abstract available


    Urologe A

  37. KUNATH F
    [Robotic versus open radical cystectomy for adults with bladder cancer].
    Urologe A. 2020 Apr 8. pii: 10.1007/s00120-020-01185.
    PubMed        


    World J Urol

  38. MARIAPPAN P, Fineron P, O'Donnell M, Gailer RM, et al
    Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up.
    World J Urol. 2020 Apr 7. pii: 10.1007/s00345-020-03180.
    PubMed         Abstract available

  39. SROUGI V, Reis ST, Viana N, Gallucci FP, et al
    Prospective evaluation of a urinary biomarker panel to detect and predict recurrence of non-muscle-invasive bladder cancer.
    World J Urol. 2020 Apr 6. pii: 10.1007/s00345-020-03188.
    PubMed         Abstract available


    Zhonghua Bing Li Xue Za Zhi


  40. [Consensus on standardized handling of specimen and pathological diagnosis of bladder cancer].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:305-310.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: